These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27898361)

  • 41. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area.
    Gervin M; Browne S; Lane A; Clarke M; Waddington JL; Larkin C; O'Callaghan E
    Am J Psychiatry; 1998 Sep; 155(9):1202-6. PubMed ID: 9734543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is non-recognition of choreic movements in Huntington disease always pathological?
    Justo D; Charles P; Daunizeau J; Delmaire C; Gargiulo M; Hahn-Barma V; Naccache L; Durr A
    Neuropsychologia; 2013 Mar; 51(4):748-59. PubMed ID: 23262076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late-onset, first-ever involuntary movement after successful surgical revascularization for pediatric moyamoya disease - Report of two cases.
    Hasegawa S; Tanaka T; Yamamoto S; Kashiwazaki D; Noguchi K; Kuroda S
    Surg Neurol Int; 2023; 14():430. PubMed ID: 38213430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cortical activities associated with voluntary movements and involuntary movements.
    Shibasaki H
    Clin Neurophysiol; 2012 Feb; 123(2):229-43. PubMed ID: 21906995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures.
    Dusick JR; Gonzalez NR; Martin NA
    Neurosurgery; 2011 Jan; 68(1):34-43; discussion 43. PubMed ID: 21150753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of COVID-19 pandemic in natural course of Moyamoya Angiopathy: an experience from tertiary-care-center in India.
    Das S; Ray BK; Ghosh R; Sengupta S; Pandit A; Dubey S
    Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):166. PubMed ID: 34924748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Moyamoya disease in China: its clinical features and outcomes.
    Duan L; Bao XY; Yang WZ; Shi WC; Li DS; Zhang ZS; Zong R; Han C; Zhao F; Feng J
    Stroke; 2012 Jan; 43(1):56-60. PubMed ID: 22020027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Moyamoya disease].
    Tokunaga K; Date I
    Brain Nerve; 2008 Jan; 60(1):37-42. PubMed ID: 18232331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unexpected movement disorders in neurosurgical practice: report of three cases.
    Taira T; Kawamura H; Tanikawa T; Iseki H; Amano K
    Surg Neurol; 1992 Aug; 38(2):135-40. PubMed ID: 1509346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antipsychotics-induced tardive syndrome: a retrospective epidemiological study.
    Lee MJ; Lin PY; Chang YY; Chong MY; Lee Y
    Clin Neuropharmacol; 2014; 37(4):111-5. PubMed ID: 24992086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Movement disorders as a manifestation of nonketotic hyperglycemia.
    Morres CA; Dire DJ
    J Emerg Med; 1989; 7(4):359-64. PubMed ID: 2600393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
    Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
    J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical analysis of benign transient shuddering-like involuntary movement in elderly people].
    Negoro K; Fukusako T; Tsuda N; Nogaki H; Morimatsu M
    Rinsho Shinkeigaku; 1994 Nov; 34(11):1153-6. PubMed ID: 7729098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Movement disorders. Keys to identifying and treating tremor.
    Velickovic M; Gracies JM
    Geriatrics; 2002 Jul; 57(7):32-6; quiz 39. PubMed ID: 12134463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Operative neurosurgery: personal view and historical backgrounds (9) Moyamoya angiopathy (MMA): past history and status presens].
    Yonekawa Y
    No Shinkei Geka; 2012 Jan; 40(1):67-87. PubMed ID: 22223526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of Moyamoya disease in the adult population with pial synangiosis.
    Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
    J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
    Khan N; Schuknecht B; Boltshauser E; Capone A; Buck A; Imhof HG; Yonekawa Y
    Acta Neurochir (Wien); 2003 Dec; 145(12):1061-71; discussion 1071. PubMed ID: 14663563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.